Status:
SUSPENDED
Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Proteinuria
Hypertension
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Chronic glomerular diseases are one of the main causes leading to end stage renal disease (ESRD). Hypertension and proteinuria are two modifiable factors promoting the progression of ESRD. Podocyte ar...
Eligibility Criteria
Inclusion
- Hypertension (TAs \> 130, TAd \> 80mmHg or under antihypertensive treatment)
- Glomerular nephropathy, proteinuria \> 1 g/day, serum creatinin \< 200 µmol/L ;
- Informed consent given ;
- No contraindication for ARB and hydrochlorothiazide ;
- Efficient contraception for women
Exclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00369538
Start Date
August 1 2006
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Néphrologie, Hôpital Civil, Hôpitaux Universitaires
Strasbourg, France, 67091